Bath & Body Works reported Q4 2024 net sales of $2.788 billion, a 4.3% decline due to an extra week in the prior year. EPS was $2.09, down from $2.55 last year. Operating income fell to $678 million, while net income dropped to $453 million. Despite these declines, results exceeded company guidance.
Bath & Body Works reported strong Q3 2024 results, exceeding net sales and earnings per diluted share guidance. Net sales increased by 3.0% to $1.61 billion, and earnings per diluted share were $0.49. The company is raising its full-year guidance to reflect this outperformance.
Bath & Body Works reported Q2 2024 net sales of $1.526 billion, a 2.1% decrease compared to the previous year. Earnings per diluted share were $0.68, while adjusted earnings per diluted share were $0.37, exceeding guidance. The company has updated its fiscal year 2024 guidance and increased its full-year expected share repurchases to $400 million.
Bath & Body Works reported net sales of $1.384 billion for Q1 2024, a decrease of 0.9% compared to $1.396 billion in Q1 2023. Earnings per diluted share were $0.38, up 9% compared to $0.35 in the same period last year. The company narrowed its full-year guidance range while raising the midpoint for both the top- and bottom-lines.
Bath & Body Works reported Q2 2023 net sales of $1.559 billion, a decrease of 3.6% compared to the previous year. EPS was $0.43, and operating income was $188 million. The company has updated its full-year forecast to reflect better-than-expected bottom line results.